Advances in Treatment of Progressive Multifocal Leukoencephalopathy.
Bernard-Valnet R, Koralnik IJ, Du Pasquier R.
Ann Neurol. 2021 Dec;90(6):865-873. doi: 10.1002/ana.26198. Epub 2021 Sep 7.
Progressive multifocal leukoencephalopathy.
Zhai S, Brew BJ.
Handb Clin Neurol. 2018;152:123-137. doi: 10.1016/B978-0-444-63849-6.00010-4.
Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab.
Varmpompiti K, Westwood AJ, Ben-Joseph A, Sibtain N, Ibrahim MAA, Stanton B, Zuckerman M, Hadden R, Ritter LM.
J Neuroimmunol. 2023 Dec 15;385:578248. doi: 10.1016/j.jneuroim.2023.578248. Epub 2023 Nov 18.
Progressive multifocal leukoencephalopathy.
Berger JR.
Handb Clin Neurol. 2014;123:357-76. doi: 10.1016/B978-0-444-53488-0.00017-1.
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.
Tan CS, Koralnik IJ.
Lancet Neurol. 2010 Apr;9(4):425-37. doi: 10.1016/S1474-4422(10)70040-5.
Progressive multifocal leukoencephalopathy.
Alstadhaug KB, Myhr KM, Rinaldo CH.
Tidsskr Nor Laegeforen. 2017 Dec 12;137(23-24). doi: 10.4045/tidsskr.16.1092. Print 2017 Dec 12.
Progressive multifocal leukoencephalopathy - epidemiology, immune response, clinical differences, treatment.
Snopková S, Štourač P, Fašaneková L, Mihalčin M, Havlíčková K, Svačinka R, Volfová P, Snopek P, Husa P.
Epidemiol Mikrobiol Imunol. 2019 Winter;68(1):24-31.
Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review.
Bohra C, Sokol L, Dalia S.
Cancer Control. 2017 Oct-Dec;24(4):1073274817729901. doi: 10.1177/1073274817729901.
[Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus].
Yukitake M.
Brain Nerve. 2019 May;71(5):493-505. doi: 10.11477/mf.1416201301.
[Progressive multifocal leukoencephalopathy in HIV-positive individuals].
Tarasov DO, Lebedev IA, Seliverstov EA.
Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(8):39-46. doi: 10.17116/jnevro202412408139.
